JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Role of systemic immune-inflammation index in predicting mortality in cancer patients in palliative care units
Abstract
Aims: In our study, we aimed to investigate whether the systemic immune-inflammation index (SII) can evaluate mortality in cancer patients treated in the palliative care unit (PCU). Material and
Methods: Cancer patients who received palliative care treatments in the PCU were screened retrospectively, and 309 patients were included in the study. The patients were divided into two groups; hospitalizations ending with discharge as Group 1 (n=154) and hospitalizations ending with exitus as Group 2 (n=155). SII values of the two groups were compared. SII was calculated with the formula of neutrophil count x platelet count / lymphocyte count. To determine the best cut-off value for the mortality distinction ability of the SII, a Receiver Operating Curve (ROC) analysis was used.
Results: The mean age and distribution of genders of the two groups were similar (p=0.706, p=0.964). There was a statistically significant difference between the SII values of the two groups (p<0.001). SII was successful in predicting mortality in cancer patients hospitalized in PCU, and the probability of mortality in patients with an SII value of 1426.29 and above at the time of hospitalization was approximately 1.8 times higher than in patients with a value below 1426.29.
Conclusion: We found that high SII values could predict mortality in cancer patients receiving palliative care in PCU. We think that SII, which is inexpensive, easily accessible, and easily calculated with only peripheral blood cell count, will provide clinicians working in PCU with important benefits, such as achieving more accurate prognostic results for the selection of treatment modalities and mortality estimation when combined with their own clinical experience. We recommend that SII be calculated in all cancer patients hospitalized in PCUs and that patients with high SII values should be followed more closely.

Keywords : Palliative care, SII, cancer, mortality

Download Article


1. Morrison RS, Meier DE. Clinical practice. Palliative care. N Engl JMed 2004; 350: 2582-90.
2. World Health Organization. Definition of Palliative Care 2020.Available from: https://www.who.int/news-room/fact-sheets/detail/palliative-care
3. World Health Organization. Global Atlas of Palliative Care 2ndEdition. London: Worldwide Palliative Care Alliance 2020.
4. Quill TE, Abernethy AP. Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med 2013; 368: 1173-5.
5. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-relatedinflammation and treatment effectiveness. Lancet Oncol 2014; 15:e493-503.
6. Padoan A, Plebani M, Basso D. Inflammation and PancreaticCancer: Focus on Metabolism, Cytokines, and Immunity. Int JMol Sci 2019; 20.
7. Crusz SM, Balkwill FR. Inflammation and cancer: advances andnew agents. Nat Rev Clin Oncol 2015; 12: 584-96.
8. Jung KW, Won YJ, Hong S, Kong HJ, Lee ES. Prediction of CancerIncidence and Mortality in Korea, 2020. Cancer Res Treat 2020;52: 351-8.
9. Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammationindex for predicting prognosis of colorectal cancer. World JGastroenterol 2017; 23: 6261-72.
10. Huang H, Liu Q, Zhu L, et al. Prognostic Value of PreoperativeSystemic Immune-Inflammation Index in Patients with CervicalCancer. Sci Rep 2019; 9: 3284.
11. Li X, Gu L, Chen Y, et al. Systemic immune-inflammation indexis a promising non-invasive biomarker for predicting the survivalof urinary system cancers: a systematic review and meta-analysis.Annals of Medicine 2021; 53: 1827-38.
12. Meneguin S, Matos TDS, Ferreira M. Perception of cancer patientsin palliative care about quality of life. Rev Bras Enferm 2018; 71:1998-2004.
13. Smith TJ, Temin S, Alesi ER, et al. American Society of ClinicalOncology provisional clinical opinion: the integration of palliativecare into standard oncology care. J Clin Oncol 2012; 30: 880-7.
14. Dulaney C, Wallace AS, Everett AS, Dover L, McDonald A, KroppL. Defining Health Across the Cancer Continuum. Cureus 2017;9: e1029.
15. Irwin KE, Greer JA, Khatib J, Temel JS, Pirl WF. Early palliative careand metastatic non-small cell lung cancer: potential mechanismsof prolonged survival. Chron Respir Dis 2013; 10: 35-47.
16. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care forpatients with metastatic non-small-cell lung cancer. N Engl J Med2010; 363: 733-42.
17. Luo H, He L, Zhang G, et al. Normal Reference Intervals ofNeutrophil-To-Lymphocyte Ratio, Platelet-To-LymphocyteRatio, Lymphocyte-To-Monocyte Ratio, and Systemic ImmuneInflammation Index in Healthy Adults: a Large Multi-CenterStudy from Western China. Clin Lab 2019; 65.
18. Lee SH, Lee JG, Choi YJ, et al. Prognosis palliative care study,palliative prognostic index, palliative prognostic score andobjective prognostic score in advanced cancer: a prospectivecomparison. BMJ Support Palliat Care 2021.
19. Stone P, Vickerstaff V, Kalpakidou A, et al. Prognostic tools orclinical predictions: Which are better in palliative care? PLoS One2021; 16: e0249763.
20. Zhou J, Xu S, Cao Z, et al. Validation of the Palliative PrognosticIndex, Performance Status-Based Palliative Prognostic Index andChinese Prognostic Scale in a home palliative care setting forpatients with advanced cancer in China. BMC Palliat Care 2020;19: 167.
21. Lolli C, Caffo O, Scarpi E, et al. Systemic Immune-InflammationIndex Predicts the Clinical Outcome in Patients with mCRPCTreated with Abiraterone. Front Pharmacol 2016; 7: 376.
22. Ji Y, Wang H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breastcancers: a meta-analysis. World J Surg Oncol 2020; 18: 197.
23. He K, Si L, Pan X, et al. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-TermSurvival Outcome in Patients With Stage I-II Gastric Cancer AfterRadical Surgery. Front Oncol 2022; 12: 829689.
24. Feng JF, Chen S, Yang X. Systemic immune-inflammation index(SII) is a useful prognostic indicator for patients with squamouscell carcinoma of the esophagus. Medicine (Baltimore) 2017; 96:e5886.
25. Murthy P, Zenati MS, Al Abbas AI, et al. Prognostic Value of theSystemic Immune-Inflammation Index (SII) After NeoadjuvantTherapy for Patients with Resected Pancreatic Cancer. Ann SurgOncol 2020; 27: 898-906.
26. Yilmaz A, Mirili C, Bilici M, Tekin SB. A novel predictor inpatients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII). J buon 2019; 24: 2127-35.
27. Huang Y, Chen Y, Zhu Y, et al. Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor ofEndometrial Cancer. Front Surg 2021; 8: 704235.
28. Yan Q, Ertao Z, Zhimei Z, et al. Systemic immune-inflammationindex (SII): A More Promising Inflammation-Based PrognosticMarker for Patients with synchronic colorectal peritonealcarcinomatosis. J Cancer 2020; 11: 5264-72.
29. Zhao LY, Yang DD, Ma XK, et al. The Prognostic Value of aspartateaminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of HepatocellularCarcinoma Patients Treated with palliative Treatments. J Cancer2019; 10: 2299-311.
30. Karn T, Pusztai L, Rody A, Holtrich U, Becker S. The Influenceof Host Factors on the Prognosis of Breast Cancer: Stroma andImmune Cell Components as Cancer Biomarkers. Curr CancerDrug Targets 2015; 15: 652-64.
Article available in :
Volume 6, Issue 2, 2023
Page : 223-227
https://doi.org/10.32322/jhsm.1227572
Article Information
Received : 31 Ara 2022
Accepted : 09 Oca 2023
Published : 27 Mar 2023
Corresponding Author :

Duygu Tutan: General Internal Medicine Clinic, Hitit University Erol Olçok Training and Research Hospital, Çorum, Turkiye

[email protected]
Citation : Tutan D, Eskin F. Role of systemic immune-inflammation index in predicting mortality in cancer patients in palliative care units. J Health Sci Med 2023; 6(2): 223-227.

Read: 187
Cited: 0
Download : 164
_Footer